Question 1

What is the catalog number for AZD-3759?

Accepted Answer

The catalog number for AZD-3759 is 9609-25.

Question 2

Is AZD-3759 in stock?

Accepted Answer

AZD-3759 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is AZD-3759 used for?

Accepted Answer

AZD-3759 is a potent epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. AZD-3759 binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR. This prevents EGFR-mediated signaling, and may lead to both induction of cell death and inhibit

Question 4

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

AZD-3759

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

C-C motif chemokine 25

C-C motif chemokine 25

DOTA-Lanreotide

Recombinant Caldivirga maquilingensis N-acetyl-gamma-glutamyl-phosphate/N-acetyl-gamma-aminoadipyl-phosphate reductase (argC)

Recombinant Caldivirga maquilingensis N-acetyl-gamma-glutamyl-phosphate/N-acetyl-gamma-aminoadipyl-phosphate reductase (argC)

Recombinant Caldivirga maquilingensis N-acetyl-gamma-glutamyl-phosphate/N-acetyl-gamma-aminoadipyl-phosphate reductase (argC)